{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:24:48Z","timestamp":1776425088888,"version":"3.51.2"},"reference-count":210,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T00:00:00Z","timestamp":1669593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Molecular recognition involving glycoprotein-mediated interactions is ubiquitous in both normal and pathological natural processes. Therefore, visualization of these interactions and the extent of expression of the sugars is a challenge in medical diagnosis, monitoring of therapy, and drug design. Here, we review the literature on the development and validation of probes for magnetic resonance imaging using carbohydrates either as targeting vectors or as a target. Lectins are important targeting vectors for carbohydrate end groups, whereas selectins, the asialoglycoprotein receptor, sialic acid end groups, hyaluronic acid, and glycated serum and hemoglobin are interesting carbohydrate targets.<\/jats:p>","DOI":"10.3390\/molecules27238297","type":"journal-article","created":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T08:13:09Z","timestamp":1669623189000},"page":"8297","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["MRI Contrast Agents in Glycobiology"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-8329","authenticated-orcid":false,"given":"Carlos F. G. C.","family":"Geraldes","sequence":"first","affiliation":[{"name":"Department of Life Sciences and Coimbra Chemistry Centre, Faculty of Science and Technology, University of Coimbra, 3000-393 Coimbra, Portugal"},{"name":"CIBIT-Coimbra Institute for Biomedical Imaging and Translational Research, 3000-548 Coimbra, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8503-1452","authenticated-orcid":false,"given":"Joop A.","family":"Peters","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Delft University of Technology, van der Maasweg 9, 2629 HZ Delft, The Netherlands"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,28]]},"reference":[{"key":"ref_1","unstructured":"Varki, A., Cummings, R.D., Esko, J.D., Stanley, P., Hart, G.W., Aebi, M., Mohnen, D., Kinoshita, T., Packer, N.H., and Prestegard, J.H. (2022). Essentials of Glycobiology, Cold Spring Harbor Laboratory Press. [4th ed.]."},{"key":"ref_2","unstructured":"Atwood, J.L. (2017). Imaging with lanthanides. Comprehensive Supramolecular Chemistry II, Elsevier."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/acsbiomaterials.1c01631","article-title":"Polysaccharide-based theranostic systems for combined imaging and cancer therapy: Recent advances and challenges","volume":"8","author":"Gupta","year":"2022","journal-title":"ACS Biomater. Sci. Eng."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Machado, V., Morais, M., and Medeiros, R. (2022). Hyaluronic acid-based nanomaterials applied to cancer: Where are we now?. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102092"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"910290","DOI":"10.3389\/fbioe.2022.910290","article-title":"Advances in hyaluronic acid for biomedical applications","volume":"10","author":"Yasin","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2100304","DOI":"10.1002\/mabi.202100304","article-title":"Advances in hyaluronic-acid-based (nano)devices for cancer therapy","volume":"22","author":"Fabozzi","year":"2022","journal-title":"Macromol. Biosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10334-021-00994-1","article-title":"What do we know about dynamic glucose-enhanced (DGE) MRI and how close is it to the clinics? Horizon 2020 GLINT consortium report","volume":"35","author":"Kim","year":"2022","journal-title":"MAGMA"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Merbach, A.E., Helm, L., and T\u00f3th, \u00c9. (2013). The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, John Wiley & Sons, Ltd.. [2nd ed.].","DOI":"10.1002\/9781118503652"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium(III) chelates as MRI contrast agents: Structure, dynamics, and applications","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Peters, J.A., and Djanashvili, K. (2016). An introduction to MRI contrast agents. Reference Module in Materials Science and Materials Engineering, Elsevier.","DOI":"10.1016\/B978-0-12-803581-8.01826-9"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmmi.265","article-title":"Classification and basic properties of contrast agents for magnetic resonance imaging","volume":"4","author":"Geraldes","year":"2009","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pierre Val\u00e9rie, C., and Allen, M.J. (2018). Contrast Agents for MRI, Experimental Methods, The Royal Society of Chemistry.","DOI":"10.1039\/9781788010146"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","article-title":"Chemistry of MRI contrast agents: Current challenges and new frontiers","volume":"119","author":"Wahsner","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17025","DOI":"10.1021\/jacs.9b09149","article-title":"Molecular magnetic resonance imaging with Gd(III)-based contrast agents: Challenges and key advances","volume":"141","author":"Li","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/RLI.0000000000000563","article-title":"Physicochemical and pharmacokinetic profiles of gadopiclenol: A new macrocyclic gadolinium chelate with high T1 relaxivity","volume":"54","author":"Robic","year":"2019","journal-title":"Investig. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.rli.0000184756.66360.d3","article-title":"Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths","volume":"40","author":"Rohrer","year":"2005","journal-title":"Investig. Radiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/mrm.22966","article-title":"Mechanisms of proton spin dephasing in a system of magnetic particles","volume":"66","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/cr068445e","article-title":"Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications","volume":"108","author":"Laurent","year":"2008","journal-title":"Chem. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/adhm.201200078","article-title":"A universal scaling law to predict the efficiency of magnetic nanoparticles as MRI T2-contrast agents","volume":"1","author":"Vuong","year":"2012","journal-title":"Adv. Healthc. Mater."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"114505","DOI":"10.1063\/1.4751442","article-title":"New simulation approach using classical formalism to water nuclear magnetic relaxation dispersions in presence of superparamagnetic particles used as MRI contrast agents","volume":"137","author":"Vuong","year":"2012","journal-title":"J. Chem. Phys."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"155706","DOI":"10.1088\/0957-4484\/27\/15\/155706","article-title":"NMR relaxation induced by iron oxide particles: Testing theoretical models","volume":"27","author":"Gossuin","year":"2016","journal-title":"Nanotechnology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/jmre.1999.1956","article-title":"A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST)","volume":"143","author":"Ward","year":"2000","journal-title":"J. Magn. Reson."},{"key":"ref_23","unstructured":"T\u00f3th, \u00c9., Helm, L., and Merbach, A. (2013). Paramagnetic CEST MRI contrast agents. The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, John Wiley & Sons Ltd.. [2nd ed.]."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Long, N., and Wong, W.-T. (2014). CEST and PARACEST agents for molecular imaging. The Chemistry of Molecular Imaging, John Wiley & Sons, Inc.","DOI":"10.1002\/9781118854754"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1021\/ar800237f","article-title":"Responsive MRI agents for sensing metabolism in vivo","volume":"42","author":"Lubag","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.mri.2007.11.002","article-title":"The detection limit of a Gd3+-based T1 agent is substantially reduced when targeted to a protein microdomain","volume":"26","author":"Hanaoka","year":"2008","journal-title":"Magn. Reson. Imaging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8611","DOI":"10.1039\/C4OB01270D","article-title":"A design strategy for small molecule-based targeted MRI contrast agents: Their application for detection of atherosclerotic plaques","volume":"12","author":"Iwaki","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1158\/1078-0432.CCR-05-1302","article-title":"The progress and promise of molecular imaging probes in oncologic drug development","volume":"11","author":"Kelloff","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/RLI.0b013e3181ee6a49","article-title":"High-relaxivity magnetic resonance imaging contrast agents part 2: Optimization of inner- and second-sphere relaxivity","volume":"45","author":"Jacques","year":"2010","journal-title":"Investig. Radiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/RLI.0b013e3181ee5a9e","article-title":"High relaxivity magnetic resonance imaging contrast agents part 1: Impact of single donor atom substitution on relaxivity of serum albumin-bound gadolinium complexes","volume":"45","author":"Dumas","year":"2010","journal-title":"Investig. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/mrm.20793","article-title":"Effect of the intracellular localization of a Gd-based imaging probe on the relaxation enhancement of water protons","volume":"55","author":"Terreno","year":"2006","journal-title":"Magn. Reson. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.addr.2010.03.011","article-title":"Tumor delivery of macromolecular drugs based on the EPR effect","volume":"63","author":"Torchilin","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/ja411793u","article-title":"Lanthanide-loaded erythrocytes as highly sensitive chemical exchange saturation transfer MRI contrast agents","volume":"136","author":"Ferrauto","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/wnan.1385","article-title":"LipoCEST and cellCEST imaging agents: Opportunities and challenges","volume":"8","author":"Ferrauto","year":"2016","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/12_2012_208","article-title":"Applications of glyconanoparticles as \u201csweet\u201d glycobiological therapeutics and diagnostics","volume":"254","author":"Kottari","year":"2013","journal-title":"Adv. Polym. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1007\/s12274-014-0507-y","article-title":"Glyconanomaterials: Emerging applications in biomedical research","volume":"7","author":"Chen","year":"2014","journal-title":"Nano Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"102542","DOI":"10.1016\/j.nano.2022.102542","article-title":"Glyco-nanotechnology: A biomedical perspective","volume":"42","author":"Kalita","year":"2022","journal-title":"Nanomed. NBM"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2174\/1568026616666161222101703","article-title":"Sugar based biopolymers in nanomedicine; new emerging era for cancer imaging and therapy","volume":"17","author":"Eroglu","year":"2017","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.addr.2006.09.013","article-title":"Recent advances in iron oxide nanocrystal technology for medical imaging","volume":"58","author":"Corot","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1039\/b402025a","article-title":"Magnetic nanoparticle design for medical diagnosis and therapy","volume":"14","author":"Mornet","year":"2004","journal-title":"J. Mater. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jmmm.2005.01.053","article-title":"A method for synthesis and functionalization of ultrasmall superparamagnetic covalent carriers based on maghemite and dextran","volume":"293","author":"Mornet","year":"2005","journal-title":"J. Magn. Magn. Mater."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jcis.2006.03.005","article-title":"Preparation and characterization of carbonyl iron\/poly(butylcyanoacrylate) core\/shell nanoparticles","volume":"299","author":"Arias","year":"2006","journal-title":"J. Colloid Interface Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF02668090","article-title":"Pre-clinical results with Clariscan\u2122 (NC100150 Injection); experience from different disease models","volume":"12","author":"Johansson","year":"2001","journal-title":"MAGMA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"10459","DOI":"10.1021\/ja111448t","article-title":"Water-dispersible sugar-coated iron oxide nanoparticles. An evaluation of their relaxometric and magnetic hyperthermia properties","volume":"133","author":"Lartigue","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Groult, H., Garc\u00eda-\u00c1lvarez, I., Romero-Ram\u00edrez, L., Nieto-Sampedro, M., Herranz, F., Fern\u00e1ndez-Mayoralas, A., and Ruiz-Cabello, J. (2018). Micellar iron oxide nanoparticles coated with anti-tumor glycosides. Nanomaterials, 8.","DOI":"10.3390\/nano8080567"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijbiomac.2020.11.205","article-title":"Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin","volume":"168","author":"Unnikrishnan","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1021\/acs.biomac.7b00797","article-title":"Family of bioactive heparin-coated iron oxide nanoparticles with positive contrast in magnetic resonance imaging for specific biomedical applications","volume":"18","author":"Groult","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"102546","DOI":"10.1016\/j.nano.2022.102546","article-title":"Preclinical evaluation of a mannose-labeled magnetic tracer for enhanced sentinel lymph node retention in the head and neck","volume":"42","author":"Krishnan","year":"2022","journal-title":"Nanomed. NBM"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0963689719834304","article-title":"D-mannose-coating of maghemite nanoparticles improved labeling of neural stem cells and allowed their visualization by ex vivo MRI after transplantation in the mouse brain","volume":"28","author":"Pongrac","year":"2019","journal-title":"Cell Transplant."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1039\/c2cs35420a","article-title":"Glyconanoparticles as multifunctional and multimodal carbohydrate systems","volume":"42","author":"Marradi","year":"2013","journal-title":"Chem. Soc. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Marradi, M., Alcantara, D., de la Fuente, J.M., Garcia-Mart\u00edn, M.L., Cerd\u00e1n, S., and Penad\u00e9s, S. (2009). Paramagnetic Gd-based gold glyconanoparticles as probes for MRI: Tuning relaxivities with sugars. Chem. Commun., 3922\u20133924.","DOI":"10.1039\/b900957d"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-3155-12-12","article-title":"A new ex vivo method to evaluate the performance of candidate MRI contrast agents: A proof-of-concept study","volume":"12","author":"Candiota","year":"2014","journal-title":"J. Nanobiotechnol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.2147\/IJN.S368458","article-title":"DOTAREM (DOTA)-gold-nanoparticles: Design, spectroscopic evaluation to build hybrid contrast agents to applications in nanomedecine","volume":"17","author":"Khan","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0006-8993(92)91135-2","article-title":"Magnetic resonance imaging of neural transplants in rat brain using a superparamagnetic contrast agent","volume":"594","author":"Norman","year":"1992","journal-title":"Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Preedy, V.R., and Watson, R.R. (2008). Tomato lectin. Tomatoes and Tomato Products Nutritional, Medicinal and Therapeutic Properties, Science Publishers, Inc.","DOI":"10.1201\/9781439843390"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00418-005-0780-7","article-title":"Design, synthesis, physical and chemical characterization, and biological interactions of lectin-targeted latex nanoparticles bearing Gd-DTPA chelates: An exploration of magnetic resonance molecular imaging (MRMI)","volume":"123","author":"Kremser","year":"2005","journal-title":"Histochem. Cell Biol."},{"key":"ref_57","first-page":"842","article-title":"Nanoparticles for diagnosis of blood vessel diseases","volume":"55","author":"Kundu","year":"2007","journal-title":"Nachr. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s11307-010-0358-1","article-title":"Lectin conjugates as biospecific contrast agents for MRI. Coupling of Lycopersicon esculentum agglutinin to linear water-soluble DTPA-loaded oligomers","volume":"13","author":"Galanski","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11307-010-0309-x","article-title":"Lectin-Gd-loaded chitosan hydrogel nanoparticles: A new biospecific contrast agent for MRI","volume":"13","author":"Kremser","year":"2011","journal-title":"Mol. Imaging Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11051-021-05157-w","article-title":"Doubly derivatized poly(lactide)-albumin nanoparticles as blood vessel-targeted transport device for magnetic resonance imaging (MRI)","volume":"23","author":"Kremser","year":"2021","journal-title":"J. Nanopart. Res."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Singh, A., Dilnawaz, F., and Sahoo, S.K. (2011). Long circulating lectin conjugated paclitaxel loaded magnetic nanoparticles: A new theranostic avenue for leukemia therapy. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026803"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1021\/mp400456j","article-title":"Lectin-conjugated Fe2O3@Au core@shell nanoparticles as dual mode contrast agents for in vivo detection of tumor","volume":"11","author":"He","year":"2014","journal-title":"Mol. Pharm."},{"key":"ref_63","unstructured":"Varki, A., Cummings, R.D., Esko, J.D., Stanley, P., Hart, G.W., Aebi, M., Mohnen, D., Kinoshita, T., Packer, N.H., and Prestegard, J.H. (2022). Discovery and classification of glycan-binding proteins. Essentials of Glycobiology, Cold Spring Harbor Laboratory Press. [4th ed.]."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0079-6123(08)80004-0","article-title":"Chapter 4\u2014Applications of nanotechnology in molecular imaging of the brain","volume":"Volume 180","year":"2009","journal-title":"Progress in Brain Research"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1021\/jm00026a004","article-title":"Rational design and synthesis of small molecule, non-oligosaccharide selectin inhibitors: \u03b1-D-mannopyranosyloxy)biphenyl-substituted carboxylic acids","volume":"38","author":"Kogan","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Fu, Y.J., Laurent, S., and Muller, R.N. (2002). Synthesis of a sialyl Lewis(X) mimetic conjugated with DTPA, potential ligand of new contrast agents for medical imaging. Eur. J. Org. Chem., 3966\u20133973.","DOI":"10.1002\/1099-0690(200212)2002:23<3966::AID-EJOC3966>3.0.CO;2-P"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1021\/bc034114m","article-title":"Synthesis and physicochemical characterization of Gd-DTPA-B(slex)A, a new MRI contrast agent targeted to inflammation","volume":"15","author":"Laurent","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.20162","article-title":"MR molecular imaging of early endothelial activation in focal ischemia","volume":"56","author":"Barber","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrm.10723","article-title":"MRI detection of early endothelial activation in brain inflammation","volume":"51","author":"Sibson","year":"2004","journal-title":"Magn. Reson. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/mrm.20403","article-title":"Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent","volume":"53","author":"Boutry","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/cmmi.87","article-title":"Specific E-selectin targeting with a superparamagnetic MRI contrast agent","volume":"1","author":"Boutry","year":"2006","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/RLI.0b013e3181a49639","article-title":"In vivo detection of inflammation using pegylated iron oxide particles targeted at E-selectin: A multimodal approach using MR imaging and EPR spectroscopy","volume":"44","author":"Radermacher","year":"2009","journal-title":"Investig. Radiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"4517","DOI":"10.2147\/IJN.S199571","article-title":"Ultrasmall superparamagnetic nanoparticles targeting E-selectin: Synthesis and effects in mice in vitro and in vivo","volume":"14","author":"Liu","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1073\/pnas.0806787106","article-title":"Glyconanoparticles allow pre-symptomatic in vivo imaging of brain disease","volume":"106","author":"Campbell","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cmmi.144","article-title":"A new macromolecular paramagnetic MR contrast agent binds to activated human platelets","volume":"2","author":"Chaubet","year":"2007","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/RLI.0b013e31819472ac","article-title":"Biomimetic MRI contrast agent for imaging of inflammation in atherosclerotic plaque of ApoE-\/-mice: A pilot study","volume":"44","author":"Alsaid","year":"2009","journal-title":"Investig. Radiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12951-021-00821-8","article-title":"Sialic acid-engineered mesoporous polydopamine dual loaded with ferritin gene and SPIO for achieving endogenous and exogenous synergistic T2-weighted magnetic resonance imaging of HCC","volume":"19","author":"Fan","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_78","first-page":"1423","article-title":"Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe3+ as a novel theranostic agent for T1\/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer","volume":"6","author":"Shu","year":"2021","journal-title":"Bioact. Mater."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nm1095-1062","article-title":"GM1 ganglioside-bound amyloid \u03b2-protein (A\u03b2): A possible form of preamyloid in Alzheimer\u2019s disease","volume":"1","author":"Yanagisawa","year":"1995","journal-title":"Nat. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1021\/cn3002015","article-title":"Glyconanoparticle aided detection of \u03b2-amyloid by magnetic resonance imaging and attenuation of \u03b2-amyloid induced cytotoxicity","volume":"4","author":"Kouyoumdjian","year":"2013","journal-title":"ACS Chem. Neurosci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1701828","DOI":"10.1002\/smll.201701828","article-title":"Detection of \u03b2-amyloid by sialic acid coated bovine serum albumin magnetic nanoparticles in a mouse model of Alzheimer\u2019s disease","volume":"14","author":"Nasr","year":"2018","journal-title":"Small"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1182\/blood-2002-12-3669","article-title":"Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells","volume":"102","author":"Hinds","year":"2003","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/mrm.20342","article-title":"Sizing it up: Cellular MRI using micron-sized iron oxide particles","volume":"53","author":"Shapiro","year":"2005","journal-title":"Magn. Reson. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1103\/PhysRev.121.1379","article-title":"Distribution of fields from randomly placed dipoles: Free-precession signal decay as result of magnetic grains","volume":"121","author":"Brown","year":"1961","journal-title":"Phys. Rev."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/mrm.1910320610","article-title":"Theory of NMR signal behavior in magnetically inhomogeneous tissues: The static dephasing regime","volume":"32","author":"Yablonskiy","year":"1994","journal-title":"Magn. Reson. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/mrm.10059","article-title":"On T2-shortening by strongly magnetized spheres: A partial refocusing model","volume":"47","author":"Gillis","year":"2002","journal-title":"Magn. Reson. Med."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1161\/ATVBAHA.111.241844","article-title":"A leukocyte-mimetic magnetic resonance imaging contrast agent homes rapidly to activated endothelium and tracks with atherosclerotic lesion macrophage content","volume":"32","author":"McAteer","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/ATVBAHA.107.145466","article-title":"Magnetic resonance imaging of endothelial adhesion molecules in mouse atherosclerosis using dual-targeted microparticles of iron oxide","volume":"28","author":"McAteer","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.atherosclerosis.2009.10.009","article-title":"An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide","volume":"209","author":"McAteer","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.vph.2012.10.005","article-title":"Targeted molecular imaging of vascular inflammation in cardiovascular disease using nano- and micro-sized agents","volume":"58","author":"McAteer","year":"2012","journal-title":"Vascul. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.bbagen.2008.10.008","article-title":"Affinity of low molecular weight fucoidan for P-selectin triggers its binding to activated human platelets","volume":"1790","author":"Bachelet","year":"2009","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1039\/c3ra46757k","article-title":"Strong and specific interaction of ultra-small superparamagnetic iron oxide nanoparticles and human activated platelets mediated by fucoidan coating","volume":"4","author":"Silva","year":"2014","journal-title":"RSC Adv."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1016\/j.actbio.2014.04.015","article-title":"Leukocyte mimetic polysaccharide microparticles tracked in vivo on activated endothelium and in abdominal aortic aneurysm","volume":"10","author":"Bonnard","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2217\/nnm.14.51","article-title":"Ultrasmall superparamagnetic iron oxide nanoparticles coated with fucoidan for molecular MRI of intraluminal thrombus","volume":"10","author":"Suzuki","year":"2015","journal-title":"Nanomedicine"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"111064","DOI":"10.1016\/j.msec.2020.111064","article-title":"Synthesis and characterization of Gd-DTPA\/fucoidan\/peptide complex nanoparticle and in vitro magnetic resonance imaging of inflamed endothelial cells","volume":"114","author":"Cheng","year":"2020","journal-title":"Mater. Sci. Eng. Proc. C"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"116457","DOI":"10.1016\/j.carbpol.2020.116457","article-title":"Gd(DOTA)-grafted submicronic polysaccharide-based particles functionalized with fucoidan as potential MR contrast agent able to target human activated platelets","volume":"245","author":"Gobin","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.bi.51.070182.002531","article-title":"Carbohydrate-specific receptors of the liver","volume":"51","author":"Ashwell","year":"1982","journal-title":"Annu. Rev. Biochem."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1152\/physrev.1995.75.3.591","article-title":"The asialoglycoprotein receptor: Relationships between structure, function, and expression","volume":"75","author":"Stockert","year":"1995","journal-title":"Physiol. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0304-4165(02)00318-5","article-title":"Glycans as endocytosis signals: The cases of the asialoglycoprotein and hyaluronan\/chondroitin sulfate receptors","volume":"1572","author":"Weigel","year":"2002","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1295\/polymj.25.355","article-title":"Body distribution of galactose-containing synthetic polymer and galactosylated albumin","volume":"25","author":"Koyama","year":"1993","journal-title":"Polym. J."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1099\/0022-1317-75-11-3021","article-title":"The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers","volume":"75","author":"Treichel","year":"1994","journal-title":"J. Gen. Virol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2214\/ajr.155.6.2122660","article-title":"MR receptor imaging: Ultrasmall iron oxide particles targeted to asialoglycoprotein receptors","volume":"155","author":"Weissleder","year":"1990","journal-title":"Am. J. Roentgenol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1148\/radiology.178.3.1994416","article-title":"Asialoglycoprotein receptor function in benign liver disease: Evaluation with MR imaging","volume":"178","author":"Reimer","year":"1991","journal-title":"Radiology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1148\/radiology.182.2.1732982","article-title":"Receptor-directed contrast agents for MR imaging: Preclinical evaluation with affinity assays","volume":"182","author":"Reimer","year":"1992","journal-title":"Radiology"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jmri.1880020210","article-title":"Dynamic signal intensity changes in liver with superparamagnetic MR contrast agents","volume":"2","author":"Reimer","year":"1992","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0730-725X(93)90074-N","article-title":"Mion-ASF: Biokinetics of an MR receptor agent","volume":"11","author":"Schaffer","year":"1993","journal-title":"Magn. Reson. Imaging"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1515\/biol-2022-0074","article-title":"Preparation and evaluation of LA-PEG-SPION, a targeted MRI contrast agent for liver cancer","volume":"17","author":"Xia","year":"2022","journal-title":"Open Life Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1148\/radiology.177.3.2243978","article-title":"Receptor imaging: Application to MR imaging of liver cancer","volume":"177","author":"Reimer","year":"1990","journal-title":"Radiology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1148\/radiology.180.3.1871273","article-title":"Experimental hepatocellular carcinoma: MR receptor imaging","volume":"180","author":"Reimer","year":"1991","journal-title":"Radiology"},{"key":"ref_110","first-page":"94740","article-title":"Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting","volume":"2007","author":"Jeong","year":"2007","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"11048","DOI":"10.1002\/chem.202002142","article-title":"Gold-speckled SPION@SiO2 nanoparticles decorated with thiocarbohydrates for ASGPR1 targeting: Towards HCC dual mode imaging potential applications","volume":"26","author":"Siciliano","year":"2020","journal-title":"Chem. Eur. J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"21093","DOI":"10.1039\/C7RA01440F","article-title":"Bioreducible amphiphilic block copolymers based on PCL and glycopolypeptide as multifunctional theranostic nanocarriers for drug delivery and MR imaging","volume":"7","author":"Yang","year":"2017","journal-title":"RSC Adv."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"18324","DOI":"10.1038\/s41598-021-97808-0","article-title":"Asialoglycoprotein receptor targeted optical and magnetic resonance imaging and therapy of liver fibrosis using pullulan stabilized multi-functional iron oxide nanoprobe","volume":"11","author":"Saraswathy","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1076-6332(05)80407-6","article-title":"A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver","volume":"2","author":"Vera","year":"1995","journal-title":"Acad. Radiol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0730-725X(94)92353-1","article-title":"Spin labelled arabinogalactan as MRI contrast agent","volume":"12","author":"Gallez","year":"1994","journal-title":"Magn. Reson. Imaging"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.carres.2014.05.022","article-title":"Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent","volume":"395","author":"Xiao","year":"2014","journal-title":"Carbohydr. Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1002\/chem.200802013","article-title":"Prospects of metal complexes peripherally substituted with sugars in biomedicinal applications","volume":"15","author":"Gottschaldt","year":"2009","journal-title":"Chem. Eur. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1002\/chem.200400187","article-title":"Lanthanide (III) complexes of DOTA-glycoconjugates: A potential new class of lectin-mediated medical imaging agents","volume":"10","author":"Geraldes","year":"2004","journal-title":"Chem. Eur. J."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/ejic.200400766","article-title":"Lanthanide (III) Chelates of DTPA bis(amide) glycoconjugates: Potential imaging agents targeted at the asyaloglycoprotein receptor","volume":"2005","author":"Geraldes","year":"2005","journal-title":"Eur. J. Inorg. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1524\/ract.2007.95.6.343","article-title":"Radiolabelled 153Sm-chelates of glycoconjugates: Multivalence and topology effects on the targeting of the asialoglycoprotein receptor","volume":"95","author":"Torres","year":"2007","journal-title":"Radiochim. Acta"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/cmmi.111","article-title":"Targeting of lanthanide (III) chelates of DOTA-type glycoconjugates to the hepatic asyaloglycoprotein receptor: Cell internalization and animal imaging studies","volume":"1","author":"Prata","year":"2006","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"8485","DOI":"10.1016\/S0040-4039(00)01488-X","article-title":"Utilization of dendritic framework as a multivalent ligand: A functionalized gadolinium(III) carrier with glycoside cluster periphery","volume":"41","author":"Takahashi","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Fulton, D.A., Elemento, E.M., Aime, S., Chaabane, L., Botta, M., and Parker, D. (2006). Glycoconjugates of gadolinium complexes for MRI applications. Chem. Commun., 1064\u20131066.","DOI":"10.1039\/b517997a"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1021\/cb700178s","article-title":"Exploring the structural diversity of mammalian carbohydrates (\u201cglycospace\u201d) by statistical databank analysis","volume":"2","author":"Werz","year":"2007","journal-title":"ACS Chem. Biol."},{"key":"ref_125","unstructured":"Varki, A., Kannagi, R., and Toole, B.P. (2009). Chapter 44: Glycosylation Changes in Cancer, Cold Spring Harbor Laboratory Press. [2nd ed.]."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s12253-015-0033-6","article-title":"Sialylation: An avenue to target cancer cells","volume":"22","author":"Vajaria","year":"2016","journal-title":"Pathol. Oncol. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2741\/e396","article-title":"Sialyltransferases functions in cancers","volume":"E4","author":"Colomb","year":"2012","journal-title":"Front. Biosci. Elite Ed."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1002\/anie.200603052","article-title":"Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma","volume":"45","author":"Lee","year":"2006","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"15982","DOI":"10.1021\/ja066547g","article-title":"Biocompatible heterostructured nanoparticles for multimodal biological detection","volume":"128","author":"Choi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ccr.2014.01.016","article-title":"Interactions between boric acid derivatives and saccharides in aqueous media: Structures and stabilities of resulting esters","volume":"268","author":"Peters","year":"2014","journal-title":"Coord. Chem. Rev."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1002\/chem.200401335","article-title":"Molecular recognition of sialic acid end groups by phenylboronates","volume":"11","author":"Djanashvili","year":"2005","journal-title":"Chem. Eur. J."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1002\/chem.200400369","article-title":"Towards targeted MRI: New MRI contrast agents for sialic acid detection","volume":"10","author":"Frullano","year":"2004","journal-title":"Chem. Eur. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cmmi.123","article-title":"Phenylboronate 160Tb complexes for molecular recognition of glycoproteins expressed on tumor cells","volume":"2","author":"Djanashvili","year":"2007","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_134","first-page":"1161","article-title":"MRI visualization of melanoma cells by targeting overexpressed sialic acid with a GdIII-dota-en-pba imaging reporter","volume":"54","author":"Alberti","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1039\/D0OB01552K","article-title":"Solid-phase synthesis and evaluation of tumour-targeting phenylboronate-based MRI contrast agents","volume":"18","author":"Martinelli","year":"2020","journal-title":"Org. Biomol. Chem."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Martinelli, J., Tei, L., Geninatti Crich, S., Alberti, D., and Djanashvili, K. (2021). Towards enhanced MRI performance of tumor-specific dimeric phenylboronic contrast agents. Molecules, 26.","DOI":"10.3390\/molecules26061730"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s11307-018-1176-0","article-title":"Tumor targeting via sialic acid: [68Ga]DOTA-en-pba as a new tool for molecular imaging of cancer with PET","volume":"20","author":"Tsoukalas","year":"2018","journal-title":"Mol. Imaging Biol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Sun, X., Cai, Y., Xu, Z., and Zhu, D. (2019). Preparation and properties of tumor-targeting MRI contrast agent based on linear polylysine derivatives. Molecules, 24.","DOI":"10.3390\/molecules24081477"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1073\/pnas.0811481106","article-title":"Imaging the glycome","volume":"106","author":"Laughlin","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1002\/anie.201410573","article-title":"Live-cell MRI with Xenon hyper-CEST biosensors targeted to metabolically labeled cell-surface glycans","volume":"54","author":"Witte","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1039\/C9TB00398C","article-title":"A polydopamine-coated LAPONITE-stabilized iron oxide nanoplatform for targeted multimodal imaging-guided photothermal cancer therapy","volume":"7","author":"Liu","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1007\/s12274-020-2839-0","article-title":"A novel clustered SPIO nanoplatform with enhanced magnetic resonance T2 relaxation rate for micro-tumor detection and photothermal synergistic therapy","volume":"13","author":"Lu","year":"2020","journal-title":"Nano Res."},{"key":"ref_143","unstructured":"Reinauer, H., Home, P.D., Kanagasabapathy, A.S., and Heuck, C.-C. (2002). Laboratory Diagnosis and Monitoring of Diabetes Mellitus."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/chem.200204632","article-title":"The structure of the sugar residue in glycated human serum albumin and its molecular recognition by phenylboronate","volume":"9","author":"Rohovec","year":"2003","journal-title":"Chem. Eur. J."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1021\/ic00062a031","article-title":"Synthesis and characterization of a novel DTPA-like gadolinium(III) complex: A potential reagent for the determination of glycated proteins by water proton NMR relaxation measurements","volume":"32","author":"Aime","year":"1993","journal-title":"Inorg. Chem."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/cmmi.141","article-title":"Molecular recognition of sugars by lanthanide (III) complexes of a conjugate of N,N-bis [2-[bis [2-(1,1-dimethylethoxy)-2-oxoethyl]amino]ethyl]glycine and phenylboronic acid","volume":"2","author":"Battistini","year":"2007","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1016\/S0006-3495(99)77426-6","article-title":"Metal complexes as allosteric effectors of human hemoglobin: An NMR study of the interaction of the gadolinium(III) bis(m-boroxyphenylamide)diethylenetriaminepentaacetic acid complex with human oxygenated and deoxygenated hemoglobin","volume":"76","author":"Aime","year":"1999","journal-title":"Biophys. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"15288","DOI":"10.1021\/ja038345f","article-title":"A paramagnetic CEST agent for imaging glucose by MRI","volume":"125","author":"Zhang","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/bc0498976","article-title":"Cyclen-based phenylboronate ligands and their Eu3+ complexes for sensing glucose by MRI","volume":"15","author":"Trokowski","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/mrm.21722","article-title":"Imaging the tissue distribution of glucose in livers using a PARACEST sensor","volume":"60","author":"Ren","year":"2008","journal-title":"Magn. Reson. Med."},{"key":"ref_151","first-page":"1178","article-title":"A new MRI PARACEST agent for sensing glucose","volume":"15","author":"Ren","year":"2007","journal-title":"Proc. Intl. Soc. Mag. Reson. Med."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Gr\u00fcnder, G. (2012). Radiopharmaceutical chemistry. Molecular Imaging in the Clinical Neurosciences, Neuromethods, Springer.","DOI":"10.1007\/978-1-61779-989-1"},{"key":"ref_154","first-page":"747","article-title":"Gd3+-DTPA-DG: Novel nanosized dual anticancer and molecular imaging agent","volume":"6","author":"Amanlou","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejrad.2010.10.021","article-title":"The synthesis of a D-glucosamine contrast agent, Gd-DTPA-DG, and its application in cancer molecular imaging with MRI","volume":"79","author":"Zhang","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1148\/radiol.2311021559","article-title":"Glucose-receptor MR imaging of tumors: Study in mice with PEGylated paramagnetic niosomes","volume":"231","author":"Luciani","year":"2004","journal-title":"Radiology"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejrad.2011.03.013","article-title":"Targeting Glut1-overexpressing MDA-MB-231 cells with 2-deoxy-D-g1ucose modified SPIOs","volume":"81","author":"Shan","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/CBM-160258","article-title":"Detection of human breast cancer cells using 2-deoxy-D-glucose-functionalized superparamagnetic iron oxide nanoparticles","volume":"18","author":"Shan","year":"2017","journal-title":"Cancer Biomark."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1166\/jnn.2016.10949","article-title":"2-Deoxy-D-glucose modified magnetic nanoparticles with dual functional properties: Nanothermotherapy and magnetic resonance imaging","volume":"16","author":"Zhao","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Merbach, A.E., Helm, L., and T\u00f3th, \u00c9. (2013). Responsive probes. The Chemistry of Contrast Agents in Medical Magnetic Resonance, John Wiley & Sons Ltd.. [2nd ed.].","DOI":"10.1002\/9781118503652"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"9840","DOI":"10.1002\/chem.201402474","article-title":"Detecting enzyme activities with exogenous MRI contrast agents","volume":"20","author":"Hingorani","year":"2014","journal-title":"Chem. Eur. J."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/anie.199707261","article-title":"A \u201csmart\u201d magnetic resonance imaging agent that reports on specific enzymatic activity","volume":"36","author":"Moats","year":"1997","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/73780","article-title":"In vivo visualization of gene expression using magnetic resonance imaging","volume":"18","author":"Louie","year":"2000","journal-title":"Nat. Biotechnol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/ar800245h","article-title":"Bioresponsive, cell-penetrating, and multimeric MR contrast agents","volume":"42","author":"Major","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/ic700888w","article-title":"Mechanistic investigation of \u03b2-galactosidase-activated MR contrast agents","volume":"47","author":"Femia","year":"2008","journal-title":"Inorg. Chem."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"12847","DOI":"10.1021\/ja042162r","article-title":"A gadolinium chelate for detection of beta-glucuronidase: A self-immolative approach","volume":"127","author":"Duimstra","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1021\/bc070019s","article-title":"Synthesis and characterization of a new bioactivated paramagnetic gadolinium (III) complex [Gd(DOTA-FPG)(H2O)] for tracing gene expression","volume":"18","author":"Chang","year":"2007","journal-title":"Bioconjug. Chem."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1002\/chem.200700785","article-title":"A Gd3+-based magnetic resonance imaging contrast agent sensitive to \u03b2-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon","volume":"14","author":"Hanaoka","year":"2008","journal-title":"Chem. Eur. J."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1021\/bc200486j","article-title":"\u03b2-Gal gene expression MRI reporter in melanoma tumor cells. Design, synthesis, and in vitro and in vivo testing of a Gd(III) containing probe forming a high relaxivity, melanin-like structure upon \u03b2-Gal enzymatic activation","volume":"22","author":"Arena","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1002\/anie.200800809","article-title":"Detection of enzymatic activity by PARACEST MRI: A general approach to target a large variety of enzymes","volume":"47","author":"Chauvin","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/chem.201101779","article-title":"Lanthanide (III) complexes that contain a self-immolative arm: Potential enzyme responsive contrast agents for magnetic resonance imaging","volume":"18","author":"Chauvin","year":"2012","journal-title":"Chem. Eur. J."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1021\/jacs.5b12084","article-title":"Prototypes of lanthanide (III) agents responsive to enzymatic activities in three complementary imaging modalities: Visible\/near-infrared luminescence, PARACEST-, and T1-MRI","volume":"138","author":"He","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1021\/acs.bioconjchem.6b00482","article-title":"Diamagnetic imaging agents with a modular chemical design for quantitative detection of \u03b2-galactosidase and \u03b2-glucuronidase activities with catalyCEST MRI","volume":"27","author":"Tucker","year":"2016","journal-title":"Bioconjug. Chem."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/mrm.22400","article-title":"S-Gal\u00ae, a novel 1H MRI reporter for \u03b2-galactosidase","volume":"64","author":"Cui","year":"2010","journal-title":"Magn. Reson. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/mrm.22235","article-title":"lacZ as a genetic reporter for real-time MRI","volume":"63","author":"Bengtsson","year":"2010","journal-title":"Magn. Reson. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cplu.201100072","article-title":"Novel Fe3+-based 1H MRI \u03b2-galactosidase reporter molecules","volume":"77","author":"Yu","year":"2012","journal-title":"ChemPlusChem"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1021\/bc049936d","article-title":"Novel NMR platform for detecting gene transfection: Synthesis and evaluation of fluorinated phenyl \u03b2-D-galactosides with potential application for assessing lacz gene expression","volume":"15","author":"Yu","year":"2004","journal-title":"Bioconjug. Chem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.mri.2006.04.003","article-title":"Imaging \u03b2-galactosidase activity using 19F chemical shift imaging of LacZ gene-reporter molecule 2-fluoro-4-nitrophenol-\u03b2-d-galactopyranoside","volume":"24","author":"Kodibagkar","year":"2006","journal-title":"Magn. Reson. Imaging"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1096\/fj.06-7366lsf","article-title":"19F-NMR detection of lacZ gene expression via the enzymic hydrolysis of 2-fluoro-4-nitrophenyl \u03b2-d-galactopyranoside in vivo in PC3 prostate tumor xenografts in the mouse","volume":"21","author":"Liu","year":"2007","journal-title":"FASEB J."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mrm.10719","article-title":"Novel NMR approach to assessing gene transfection: 4-fluoro-2-nitrophenyl-\u03b2-D-galactopyranoside as a prototype reporter molecule for \u03b2-galactosidase","volume":"51","author":"Cui","year":"2004","journal-title":"Magn. Reson. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/cmmi.1470","article-title":"A smart 19F and 1H MRI probe with self-immolative linker as a versatile tool for detection of enzymes","volume":"7","author":"Keliris","year":"2012","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1039\/c1sc00071c","article-title":"19F MRI detection of [small beta]-galactosidase activity for imaging of gene expression","volume":"2","author":"Mizukami","year":"2011","journal-title":"Chem. Sci."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1158\/0008-5472.CAN-04-3947","article-title":"Magnetic resonance imaging visualization of hyaluronidase in ovarian carcinoma","volume":"65","author":"Shiftan","year":"2005","journal-title":"Cancer Res."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/cmmi.96","article-title":"Kinetic analysis of hyaluronidase activity using a bioactive MRI contrast agent","volume":"1","author":"Shiftan","year":"2006","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"12909","DOI":"10.1039\/c2ra21888g","article-title":"Enzymatically triggered multifunctional delivery system based on hyaluronic acid micelles","volume":"2","author":"Deng","year":"2012","journal-title":"RSC Adv."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1002\/mrm.22839","article-title":"Release activation of iron oxide nanoparticles: (REACTION) A novel environmentally sensitive MRI paradigm","volume":"65","author":"Granot","year":"2011","journal-title":"Magn. Reson. Med."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Merbach Andre, E., Helm, L., and T\u00f3th, \u00c9. (2013). Stability and toxicity of contrast agents. Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, John Wiley & Sons Ltd.. [2nd ed.].","DOI":"10.1002\/9781118503652"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2015150805","article-title":"Residual or retained gadolinium: Practical implications for radiologists and our patients","volume":"275","author":"Kanal","year":"2015","journal-title":"Radiology"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1002\/chem.201405967","article-title":"The role of equilibrium and kinetic properties in the dissociation of Gd[DTPA-bis(methylamide)] (Omniscan) at near to physiological conditions","volume":"21","author":"Baranyai","year":"2015","journal-title":"Chem. Eur. J."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1148\/radiol.13131669","article-title":"High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: Relationship with increasing cumulative dose of a gadolinium-based contrast material","volume":"270","author":"Kanda","year":"2014","journal-title":"Radiology"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/RLI.0000000000000241","article-title":"Linear gadolinium-based contrast agents are associated with brain gadolinium retention in healthy rats","volume":"51","author":"Robert","year":"2016","journal-title":"Investig. Radiol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.2015142690","article-title":"Gadolinium-based contrast agent accumulates in the brain even in subjects without severe renal dysfunction: Evaluation of autopsy brain specimens with inductively coupled plasma mass spectroscopy","volume":"276","author":"Kanda","year":"2015","journal-title":"Radiology"},{"key":"ref_193","unstructured":"(2022, November 16). EMA\u2019s Final Opinion Confirms Restrictions on Use of Linear Gadolinium Agents in Body Scans. Available online: https:\/\/www.ema.europa.eu\/en\/news\/emas-final-opinion-confirms-restrictions-use-linear-gadolinium-agents-body-scans."},{"key":"ref_194","unstructured":"(2022, November 16). FDA Drug Safety Communication: FDA Identifies No Harmful Effects to Date with Brain Retention of Gadolinium-Based Contrast Agents for MRIs; Review to Continue, Available online: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-identifies-no-harmful-effects-date-brain-retention-gadolinium."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/RLI.0000000000000764","article-title":"Pharmacokinetics, dialysability, and safety of gadopiclenol, a new gadolinium-based contrast agent, in patients with impaired renal function","volume":"56","author":"Bradu","year":"2021","journal-title":"Investig. Radiol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4155\/fmc-2018-0608","article-title":"Mn(II) compounds as an alternative to Gd-based MRI probes","volume":"11","author":"Botta","year":"2019","journal-title":"Future Med. Chem."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.2147\/IJN.S218085","article-title":"Manganese Oxide Nanoparticles as MRI Contrast Agents in Tumor Multimodal Imaging and Therapy","volume":"14","author":"Cai","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"11138","DOI":"10.1039\/D1SC02200H","article-title":"Defining the conditions for the development of the emerging class of FeIII based MRI contrast agents","volume":"12","author":"Baranyai","year":"2021","journal-title":"Chem. Sci."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/acs.accounts.2c00102","article-title":"Morrow, Distinct coordination chemistry of Fe(III)-based MRI probes","volume":"55","author":"Kras","year":"2022","journal-title":"Acc. Chem. Res."},{"key":"ref_200","unstructured":"Botta, M., Geraldes, C.F.G.C., and Tei, L. (2022). High spin Fe(III)-doped nanostructures as T1 MR imaging probes. WIREs Nanomed. Nanobiotechnol., e1858."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4155\/fmc.09.164","article-title":"Magnetic iron oxide nanoparticles for biomedical applications","volume":"2","author":"Laurent","year":"2010","journal-title":"Future Med. Chem."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jmmm.2006.10.1188","article-title":"Enhanced ferrite nanoparticles as MRI contrast agents","volume":"311","author":"Shultz","year":"2007","journal-title":"J. Magn. Magn. Mater."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.pnmrs.2020.07.002","article-title":"Relaxivity of manganese ferrite nanoparticles","volume":"120\u2013121","author":"Peters","year":"2020","journal-title":"Prog. Nucl. Magn. Reason. Spectrosc."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/978-1-61779-219-9_28","article-title":"Manganese-enhanced magnetic resonance imaging","volume":"Volume 771","author":"Faber","year":"2011","journal-title":"In Vivo NMR Imaging, Methods and Protocols"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/em.21909","article-title":"Effects of iron oxide nanoparticles: Cytotoxicity, genotoxicity, developmental toxicity, and neurotoxicity","volume":"56","author":"Valdiglesias","year":"2015","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/17435390.2020.1842934","article-title":"Organ-specific toxicity of magnetic iron oxide-based nanoparticles","volume":"15","author":"Chrishtop","year":"2021","journal-title":"Nanotoxicology"},{"key":"ref_207","doi-asserted-by":"crossref","unstructured":"Malhotra, N., Lee, J.S., Liman, R.A.D., Ruallo, J.M.S., Villaflores, O.B., Ger, T.R., and Hsiao, C.D. (2020). Potential toxicity of iron oxide magnetic nanoparticles: A review. Molecules, 25.","DOI":"10.3390\/molecules25143159"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/acs.chemrestox.6b00298","article-title":"For Better or Worse, Iron Overload by Superparamagnetic Iron Oxide Nanoparticles as a MRI Contrast Agent for Chronic Liver Diseases","volume":"30","author":"Zhou","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.rli.0000191370.52737.75","article-title":"The cost of developing imaging agents for routine clinical use","volume":"41","author":"Nunn","year":"2006","journal-title":"Investig. Radiol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2967\/jnumed.112.107615","article-title":"Barriers to clinical translation with diagnostic drugs","volume":"54","author":"Josephson","year":"2013","journal-title":"J. Nucl. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/23\/8297\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:28:31Z","timestamp":1760146111000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/23\/8297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,28]]},"references-count":210,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["molecules27238297"],"URL":"https:\/\/doi.org\/10.3390\/molecules27238297","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,28]]}}}